Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

28.19
-0.9100-3.13%
Post-market: 28.540.3500+1.24%19:54 EDT
Volume:896.48K
Turnover:25.40M
Market Cap:2.47B
PE:-21.94
High:29.40
Open:29.02
Low:28.16
Close:29.10
52wk High:39.28
52wk Low:16.82
Shares:87.67M
Float Shares:81.82M
Volume Ratio:1.03
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2849
EPS(LYR):-1.2849
ROE:-10.92%
ROA:-8.92%
PB:2.42
PE(LYR):-21.94

Loading ...

IDEAYA Biosciences grants inducement stock options for 237,800 shares at $29.1 each

Reuters
·
Yesterday

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Yesterday

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Butterfly Network (BFLY), IDEAYA Biosciences (IDYA) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Apr 30

Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA

TIPRANKS
·
Apr 30

IDEAYA Biosciences: to Initiate Nda Submission From Darovasertib Optimum-02 Trial

THOMSON REUTERS
·
Apr 30

IDEAYA Biosciences Inc - to Initiate Rtor Submission in May, Nda Filing Completion Expected in H2 2026

THOMSON REUTERS
·
Apr 30

FDA agrees to review IDEAYA darovasertib-crizotinib NDA under RTOR program

Reuters
·
Apr 30

IDEAYA Biosciences announces annual shareholder meeting

Reuters
·
Apr 30

IDEAYA And AstraZeneca Collaboration Adds New Dimension To IDE849 And Valuation

Simply Wall St.
·
Apr 22

IDEAYA to present complete OptimUM-02 darovasertib-crizotinib trial data at ASCO 2026

Reuters
·
Apr 21

IDEAYA Biosciences Inc : JP Morgan Raises Target Price to $81 From $78

THOMSON REUTERS
·
Apr 15

IDEAYA Biosciences Inc : Stephens Raises Target Price to $48 From $45

THOMSON REUTERS
·
Apr 15

Ideaya Biosciences Stock Not Fully Reflecting Phase 2/3 Data From Metastatic Uveal Melanoma Study, RBC Says

MT Newswires Live
·
Apr 14

IDEAYA Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 14

Ideaya Biosciences price target raised to $54 from $50 at Guggenheim

TIPRANKS
·
Apr 14

IDEAYA Biosciences Inc : Truist Securities Raises Target Price to $65 From $60

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences, Inc. : Wells Fargo Raises Target Price to $48 From $44

THOMSON REUTERS
·
Apr 14

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

IDEAYA Biosciences Inc : Leerink Partners Raises Target Price to $37 From $34

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences Inc : Guggenheim Raises Target Price to $54 From $50

THOMSON REUTERS
·
Apr 14